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We describe subarachnoid hemorrhage (SAH) in a 66-year-old man, who underwent technically successful carotid
stenting for a string-stenosis of the right internal carotid artery (ICA) in a presence of contralateral ICA occlusion with
recurrent right hemisphere transient ischemic attacks. At 2 hours, the patient developed headache and vomiting, but no
focal neurological deficits. Performed transcranial color-coded Doppler (TCCD) showed over 2.8-fold increase of the
peak systolic velocity in the right middle cerebral artery. The emergent CT of the brain showed SAH with the right
hemisphere edema. Patient was treated with Nimodipine in continuous infusion, diuretics i.v. and additional hypotensive
therapy depending on blood pressure values. Clopidogrel was stopped for 5 days. Over next 4 weeks, a gradual cerebral
velocities decrease was observed on TCCD, which was related to clinical and CT resolution. (J Vasc Surg 2007;45:
1072-5.)Reperfusion injury is a rare but life threatening compli-
cation following carotid endarterectomy (CEA) and ca-
rotid artery stenting (CAS).1-3 It may manifest as hyperper-
fusion syndrome with brain edema, intracranial
hemorrhage (ICH), or subarachnoid hemorrhage
(SAH).1-4 The latter one is described very rarely. Occur-
rence of ICH carries a risk of death estimated at 37% to
80%.4
CASE REPORT
We report the case of a 66-year-old man with left internal
carotid artery (ICA) occlusion and right ICA string-stenosis on
duplex ultrasound and multislice computed tomography angiog-
raphy (Fig 1), referred to our department to determine further
management. The right ICA stenosis was highly symptomatic with
recurrent transient ischemic attacks (TIA), including amaurosis
fugax and left arm weakness which occurred three times during the
week prior to admission. CT scans showed no detectable brain
lesions (Fig 2, A2).
The patient was a former smoker with drug-resistant hyper-
tension, exertion angina, diabetes, and hyperlipidemia. Laboratory
tests showed elevated serum creatinine level (1.54 mg/dl). Signif-
icant bilateral renal artery stenosis was detected by duplex ultra-
sound. The patient had been taking aspirin (75mg o.d.) for 2 years
and clopidogrel (75 mg o.d) for 5 days prior to admission.
Angiography confirmed 95% lumen reduction in the right
ICA (string-stenosis) with plaque ulceration (Fig 3, A), significant
cerebral flow impairment (Fig 3, B), and bilateral renal artery
stenosis. In addition, the right coronary artery stenosis was de-
tected. Further patient management was discussed with an endo-
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1072vascular surgeon and an independent neurologist. The decision of
a two-stage endovascular treatment was made. The highly symp-
tomatic ICA stenosis was to be treated first (CAS), with the
coronary and renal angioplasty 2 to 3 weeks later.
Despite contralateral ICA occlusion, a proximal neuroprotec-
tion by flow reversal (Gore NPS, Flagstaff, Ariz) was chosen due to
normal vertebral arteries and the functional collateral flow from the
posterior cerebral arteries to the middle cerebral arteries (MCA)
through the both posterior communicating arteries.5 The proce-
dure was uneventful and the angiographic result was optimal (Fig
3, D) with an excellent blood flow to the right middle and anterior
cerebral arteries as well as to the left ones through the anterior
communicating artery (Fig 3, C).
Arterial blood pressure prior to CAS was 150/90 to 170/100
mm Hg, but there were episodes of rapid elevations up to 200/
110 mm Hg. During CAS, blood pressure measured with arterial
catheter ranged 150/70 to 170/90mmHg. Just after CAS, blood
pressure monitored and measured by an automatic cuff, ranged
130/70 to 140/80 mm Hg.
Two hours after CAS, the patient began to complain of
headache, followed by nausea and vomiting with no focal neuro-
logical deficits. There was blood pressure elevation to 180/95 mm
Hg. Transcranial color-coded Doppler (TCCD) demonstrated
2.8-fold increase in the peak systolic velocity (PSV) in MCA
compared with the values prior to CAS (Fig 2, A1, B1). Emergent
brain CT showed SAHwith bilateral hemisphere edema which was
significantly more prominent on the right (Fig 2, B2). Careful
retrospective evaluation of cerebral angiography showed no vascu-
lar malformation or cerebral aneurysm.
The patient was administrated Nimodipine in continuous
intravenous infusion (initial dose of 2 mg/hour), Mannitol 125
mg and Furosemide 10 to 20 mg every 8 hours (i.v.), and hypo-
tensive drugs (beta-blockers, clonidine, spironolactone, ACE in-
hibitors) to keep blood pressure below 160/100 mm Hg. Clopi-
dogrel, but not aspirin, was stopped for 5 days to possibly reduce
the risk of recurrent cerebral bleeding. Blood pressure, ECG, and
serum electrolytes concentration were controlled. The headache
began to decrease 1 week after CAS and a full recovery occurred
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Volume 45, Number 5 Przewlocki et al 1073Fig 1. Multislice computed tomography angiography. A, the right ICA string-stenosis; B, occlusion of the left ICA.
Doppler ultrasound. C, occlusion of the left ICA; D, the right ICA string-stenosis. Transcranial color-coded Doppler
of the Willis circle. E, yellow arrow shows patent posterior communicating artery (PCoA) situated between the right
middle cerebral artery (RMCA) and the right posterior cerebral artery (RPCA); F, spectrum registered in the PCoA
indicates blood flow from the RPCA to the RMCA.Fig 2. Images in the upper raw present TCCD findings: A1, prior to CAS, decreased PSV (62 cm/s) in the right
MCA, posterior communicating artery (arrow); B1, after CAS, 2.8-fold PSV increase in the right MCA (PSV-175
cm/s); C1, 2 weeks after CAS, slow decrease of MCA PSV (133 cm/s); D1, 4 weeks after CAS, normalization of the
right MCA PSV (92 cm/s) Images in the lower raw present CT findings: A2, prior to CAS, normal CT scan; B2, after
CAS, subarachnoid hemorrhage with bilateral hemisphere edema;C2, 2 weeks after CAS, the right hemisphere edema,
previously seen blood is absorbed; D2, 4 weeks after CAS, complete lesions’ resolution.
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Repeated duplex ultrasound showed patent stent without
thrombus formation. Every day, follow-up TCCD showed a
slow gradual PSV decrease in the right MCA from the day 8,
with velocity normalization 4 weeks later (Fig 2, C1, D1).
Control brain CT showed blood absorption on the day 13 and
complete edema resolution on the day 29 (Fig 2, C2, D2).
The patient was discharged from the hospital after 5 weeks
following CAS. Onemonth later, he underwent successful stenting
of coronary and both renal arteries. He remains asymtomatic and
his blood pressure is below 140/80 mm Hg at the 4-month
follow-up.
DISCUSSION
The presented patient required multisite interventions
for multilevel symptomatic atherosclerosis. Recurrent cere-
bral TIAs prompted the decision to perform CAS first to
prevent a disabling stroke. CEA was turned down due to
the high risk of periprocedural complications related to
symptomatic angina and contralateral ICA occlusion.6,7
With the unfavorable right ICA plaque morphology, the
significant risk of cerebral embolization during CAS was in
part reduced by the choice of a proximal neuroprotection
system that works already prior to lesion crossing.8
Despite the uneventful CAS procedure, the patient
developed headache in the absence of any focal neurologi-
cal deficit. The TCCD finding of the 2.8-fold PSV increase
in the right MCA was highly suggestive of reperfusion
injury and was followed by an immediate CT. The over
twofoldMCAPSV increase was described particularly often
in ICH.1,9,10 Surprisingly, CT scans showed SAH. The
controversy remains about mechanism of SAH after CAS.
This disorder occurs usually in the setting of coexisting
malformation or cerebral aneurysm.4 Those were not
found on angio-CT and angiography in this case; however,
the microscopic A-V malformations cannot be excluded.
Our TCCD findings of 2.8-fold MCA PSV increase
Fig 3. Angiography of the right ICA and cerebral arte
causing string-stenosis; impaired cerebral flow. C, D, jus
the right and left middle and anterior cerebral arteries.may suggest similar mechanism of both ICH and SAHrelated to autoregulation loss. Prolonged ischemia due
to bilateral ICA disease is responsible for maximal dila-
tion of small arterioles to ensure adequate blood flow.
However, when the normal perfusion pressure is re-
stored with CEA or CAS, the arterioles are unable to
reconstrict adequately in order to protect the brain tis-
sue, leading to the reperfusion injury.11 In those circum-
stances, TCCD can be very helpful in selection of pa-
tients at risk for reperfusion injury. We believe that in
patients with marked postprocedural MCA PSV increase,
a tight blood pressure control should be introduced. In
our institution, TCCD examination is performed rou-
tinely prior to CAS. Postprocedural TCCD evaluation
is performed in patients considered “high risk”, and
always in the setting of headache or neurological com-
plications.
Reperfusion injury occurs in 0.4% to 4% of patients after
CEA and in 0.67% to 5% of patients undergoing CAS,1-4
and it occurs sooner after CAS (within hours or 1 to 2 days)
than CEA (2 to 17 days). 2 In our database of 425 consec-
utive CAS procedures, there were four (0.9%) hemorrhages
(three ICH, one SAH). Uncontrollable hypertension in the
setting of bilateral renal artery stenosis in addition to con-
tralateral ICA occlusion made the described patient very
prone to reperfusion injury.1-3,12 Also, routine dual anti-
platelet therapy in patients undergoing CAS may contrib-
ute to its incidence.
SAH is the most rarely described type of reperfusion
injury.13,14 This devastating condition carries a 20% to
30% risk of rebleeding during first month, cerebral artery
vasospasm (usually between 5 to 14 days), which may
progress to cerebral infarction and neurological defi-
cits.15 Nimodipine is recommended to reduce poor out-
come related to vasospasm.15 Bed rest and antihyperten-
sive therapy is frequently used to prevent rebleeding.15
However, the issue of dual antiplatelet therapy remains
unresolved. Two described cases of SAH following CAS
were fatal.13,14 Thus, we decided to stop clopidogrel
A, B, prior to CAS, soft ulcerated plaque in right ICA
r CAS, a good angiographic result after CAS and flow tories.
t afte(not aspirin) for 5 days.
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